Clinical Trials Browser

Completed × Immunoglobulin Light-chain Amyloidosis × daratumumab × Clear all

NCT04304144 2025-03-05

A Study to Evaluate the Safety and Tolerability of CAEL-101 in Patients With AL Amyloidosis

Phase 2 Completed

25 enrolled 14 charts

Immunoglobulin Light-chain Amyloidosis

NCT02841033 2021-05-07

Daratumumab for the Treatment of Patients With AL Amyloidosis

Phase 1/2 Completed

22 enrolled 10 charts

Immunoglobulin Light-chain Amyloidosis